Next Generation Phenotypic Screening: Part of a Balanced Strategy for Accelerating Drug Discovery

This whitepaper reviews major pharmaceutical companies that have expanded the use of phenotypic drug discovery and examines the challenges of phenotypic screening, including the remaining technology gaps and underserved model systems.